Versant Capital Management’s Kestra Medical Technologies KMTS Stock Holding History

Versant Capital Management’s Portfolio KMTS Stock Details KMTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$6.7K	Hold	237	–	–	﹤0.01%	2388
2026 Q2	$6.03K	Buy	237 +208	+717%	+$4.36K	﹤0.01%	2392
2026 Q1	$578	Buy	+29	New	+$683	﹤0.01%	2712

Other funds holding KMTS

Andera Partners Paris $176M AUM 1.8% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Versant Capital Management's KMTS Position: Q3 2026 in Review

Versant Capital Management held its Kestra Medical Technologies (KMTS) position steady in Q3 2026 at 237 shares worth $6.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2388.

Versant Capital Management first reported a position in KMTS in Q1 2026 and has held it in 3 quarters since. 7 funds tracked by Wall St. Rank hold KMTS as of Q3 2026.

Versant Capital Management held 237 shares of Kestra Medical Technologies worth $6.7K as of Q3 2026.
Versant Capital Management left its Kestra Medical Technologies share count unchanged in Q3 2026.
Kestra Medical Technologies made up ﹤0.01% of Versant Capital Management's portfolio in Q3 2026, its #2388 holding.
Versant Capital Management first reported a position in Kestra Medical Technologies in Q1 2026 and has held it in 3 quarters since.
7 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q3 2026.

Based on Versant Capital Management's 13F filing for Q3 2026, filed 2 Oct 2026.